Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10

doi:10.1084/jem.177.2.295

This Article

	Full Text (PDF, 1136K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Burdin, N.
	Articles by Rousset, F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Burdin, N.
	Articles by Rousset, F.


Social Bookmarking

	What's this?

ARTICLES

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10

N Burdin, C Peronne, J Banchereau and F Rousset
Laboratory for Immunological Research, Schering-Plough, Dardilly, France.

Interleukin 10 (IL-10) is a pleiotropic factor that enhances proliferation of activated human B lymphocytes and induces them to secrete high amounts of immunoglobulins. Here we show that several human B cell lines were able to constitutively secrete human (h)IL-10. Whereas none of the pre-B nor the plasmocytic cell lines tested produced hIL-10, 25 of the 36 tested mature B cell lines (lymphoblastoid and Burkitt lymphoma cell lines) secreted hIL-10. Moreover, 24 of these 25 hIL-10-producing B cell lines contained the Epstein-Barr virus (EBV) genome, suggesting a relationship between hIL- 10 production by human B cell lines and EBV expression. Accordingly, whereas polyclonal activation via triggering of surface immunoglobulins or CD40 antigen induced highly purified normal human B lymphocytes to produce only low (0.3-0.4 ng/ml) but significant amounts of hIL-10, EBV infection induced them to secrete high amounts of hIL-10 (4-9 ng/ml). Furthermore, addition of exogenous hIL-10, simultaneously to EBV infection, potentiated cell proliferation, whereas a blocking anti-IL- 10 antiserum inhibited it. Thus, hIL-10 produced by infected human B lymphocytes appears to be involved in the mechanisms of EBV-induced B cell proliferation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Thusberg, J., Vihinen, M. (2007). The structural basis of hyper IgM deficiency - CD40L mutations. Protein Eng Des Sel 20: 133-141 [Abstract] [Full Text]
Kis, L. L., Takahara, M., Nagy, N., Klein, G., Klein, E. (2006). IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Blood 107: 2928-2935 [Abstract] [Full Text]
Flano, E., Kayhan, B., Woodland, D. L., Blackman, M. A. (2005). Infection of Dendritic Cells by a {gamma}2-Herpesvirus Induces Functional Modulation. J. Immunol. 175: 3225-3234 [Abstract] [Full Text]
Ogden, C. A., Pound, J. D., Batth, B. K., Owens, S., Johannessen, I., Wood, K., Gregory, C. D. (2005). Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt's Lymphoma. J. Immunol. 174: 3015-3023 [Abstract] [Full Text]
Nepomuceno, R. R., Balatoni, C. E., Natkunam, Y., Snow, A. L., Krams, S. M., Martinez, O. M. (2003). Rapamycin Inhibits the Interleukin 10 Signal Transduction Pathway and the Growth of Epstein Barr Virus B-cell Lymphomas. Cancer Res. 63: 4472-4480 [Abstract] [Full Text]
Khanolkar, A., Fu, Z., Underwood, L. J., Bondurant, K. L., Rochford, R., Cannon, M. J. (2003). CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells. J. Immunol. 170: 3187-3194 [Abstract] [Full Text]
MacKay, K., Milicic, A., Lee, D., Tikly, M., Laval, S., Shatford, J., Wordsworth, P. (2003). Rheumatoid arthritis susceptibility and interleukin 10: a study of two ethnically diverse populations. Rheumatology (Oxford) 42: 149-153 [Abstract] [Full Text]
Grondal, G, Traustadottir, K H, Kristjansdottir, H, Lundberg, I, Klareskog, L, Erlendsson, K, Steinsson, K (2002). Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus 11: 435-442 [Abstract]
Alas, S., Emmanouilides, C., Bonavida, B. (2001). Inhibition of Interleukin 10 by Rituximab Results in Down-Regulation of Bcl-2 and Sensitization of B-cell Non-Hodgkin's Lymphoma to Apoptosis. Clin. Cancer Res. 7: 709-723 [Abstract] [Full Text]
Spieker, T., Herbst, H. (2000). Distribution and Phenotype of Epstein-Barr Virus-Infected Cells in Inflammatory Bowel Disease. Am. J. Pathol. 157: 51-57 [Abstract] [Full Text]
Knappe, A., Hör, S., Wittmann, S., Fickenscher, H. (2000). Induction of a Novel Cellular Homolog of Interleukin-10, AK155, by Transformation of T Lymphocytes with Herpesvirus Saimiri. J. Virol. 74: 3881-3887 [Abstract] [Full Text]
Morimoto, S., Kanno, Y., Tanaka, Y., Tokano, Y., Hashimoto, H., Jacquot, S., Morimoto, C., Schlossman, S. F., Yagita, H., Okumura, K., Kobata, T. (2000). CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses. J. Immunol. 164: 4097-4104 [Abstract] [Full Text]
Chapoval, A. I., Tamada, K., Chen, L. (2000). In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 95: 2346-2351 [Abstract] [Full Text]
Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97: 1695-1700 [Abstract] [Full Text]
Kaye, K. M., Izumi, K. M., Li, H., Johannsen, E., Davidson, D., Longnecker, R., Kieff, E. (1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation. J. Virol. 73: 10525-10530 [Abstract] [Full Text]
Jones, K. D., Aoki, Y., Chang, Y., Moore, P. S., Yarchoan, R., Tosato, G. (1999). Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous Growth of Kaposi's Sarcoma Herpesvirus-Associated Infected Primary Effusion Lymphoma Cells. Blood 94: 2871-2879 [Abstract] [Full Text]
Saito, I., Haruta, K., Shimuta, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda, T., Hayashi, Y., Tsubota, K. (1999). Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10. J. Immunol. 162: 2488-2494 [Abstract] [Full Text]
Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J., Enk, A. H. (1999). Interleukin-10-Treated Human Dendritic Cells Induce a Melanoma-Antigen-Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells. Blood 93: 1634-1642 [Abstract] [Full Text]
Bejarano, M.T., Masucci, M.G. (1998). Interleukin-10 Abrogates the Inhibition of Epstein-Barr Virus-Induced B-Cell Transformation by Memory T-Cell Responses. Blood 92: 4256-4262 [Abstract] [Full Text]
Satterthwaite, A. B., Rawlings, D. J., Witte, O. N. (1998). DSHP: A "power bar" for sustained immune responses?. Proc. Natl. Acad. Sci. USA 95: 13355-13357 [Full Text]
Kuan, N.-K., Passaro, E. Jr (1998). Apoptosis: Programmed Cell Death. Arch Surg 133: 773-775 [Full Text]
Punnonen, J., Cocks, B. G., Carballido, J. M., Bennett, B., Peterson, D., Aversa, G., Vries, J. E.�d. (1997). Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes. JEM 185: 993-1004 [Abstract] [Full Text]
Tan, J. C., Braun, S., Rong, H., DiGiacomo, R., Dolphin, E., Baldwin, S., Narula, S. K., Zavodny, P. J., Chou, C.-C. (1995). Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor. J. Biol. Chem. 270: 12906-12911 [Abstract] [Full Text]